Natus Medical Shareholders Equity Trend

Natus Medical Incorporated -- USA Stock  

USD 30.95  0.25  0.81%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Shareholders Equity of Natus Medical Incorporated with missing and latest data points interpolated. A principal component of the balance sheet, in addition to Total Liabilities and Total Assets, that represents the total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.
Shareholders Equity  10 Years Trend  
Increasing
Slightly volatile
 Shareholders Equity 
      Timeline 

Natus Medical Shareholders Equity Over Time

2016-12-31  417,374,000 
2017-12-31  417,374,000 
2018-12-31  425,307,368 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  288,432,490
Geometric Mean  258,028,866
Coefficient Of Variation  39.56
Mean Deviation  89,399,912
Median  268,752,000
Standard Deviation  114,109,562
Range  364,278,368
R Value  0.96
R Squared  0.92
Significance  0.00000017
Slope  28,165,551

Currently Trending

V   
 NYQ 
Sold over 20 shares of
a day ago ago
Traded for 121.85
S   
 NYQ 
Purchased over 500 shares of
a day ago ago
Traded for 5.39
F   
 NYQ 
Purchased over 200 shares of
a day ago ago
Traded for 10.61